03:04 , Jun 30, 2018 |  BioCentury  |  Finance

Eyes on launches

The annual summer slowdown isn’t restricted to just the stock market this year, as the clinical catalyst calendar also appears to be on holiday in 3Q18. Buysiders are therefore turning their attention to a spate of...
19:05 , Dec 8, 2017 |  BC Week In Review  |  Financial News

French Orphan play Advicenne raises EUR27M IPO

Advicenne S.A. (Euronext:ADVIC) lost €0.03 to €14 on its first day of trading Dec. 6 after it raised €27 million ($32.1 million) through the sale of 1.9 million shares at €14.03 in an IPO on...
00:41 , Dec 6, 2017 |  BC Extra  |  Financial News

French Orphan play Advicenne raises €27M IPO

Advicenne S.A. (Euronext:ADVIC) lost €0.03 to €14 on its first day of trading Wednesday after it raised €27 million ($32.1 million) through the sale of 1.9 million shares at €14.03 in an IPO on Euronext...
18:50 , Oct 27, 2017 |  BC Week In Review  |  Clinical News

Advicenne reports Phase III data for renal tubular acidosis candidate

In September, Advicenne Pharma S.A. (Nimes, France) reported data from a Phase III trial showing that among 30 evaluable patients with distal renal tubular acidosis, twice-daily oral ADV7103 was superior to standard of care (SOC)...